0

Nasal Spray Vaccine Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21649

Download Sample Report download
Buy the Full ReportStarting from $3999
Published on

January 2022

Total pages

245

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3999

About the Report

About the Report

Oral and Intramuscular vaccination has been considered till date as the ultimate ways, but nasal route offers advantages such as ease of self administration and induction of mucosal as well as systemic immunity. Both liquid and dry powder formulations can be given via intranasal route. A great consideration has to be given while selecting a suitable device for nasal administration since the volume delivered is very low.
A number of devices are available based on number of doses to be administered and type of dosage formulation. An intranasal vaccine stimulates a broad immune response that neutralizes IgG, mucosal IgA, and T cell receptors. Immune responses at the site of infection (in the nasal mucosa) are essential for blocking both infection and transmission of COVID-19. The nasal route has excellent potential for vaccination due to the organized immune systems of the nasal mucosa.
The nasal vaccine process is non-invasive and needle free. There is also an ease of administration and does not require trained health care workers. This eliminates needle-associated risks such as injuries and infections. Nasal spray vaccines have a high compliance rate and ideally suits for children's and adults. Nasal vaccines can also be manufactured in a large scale and thus will be able to meet the global demand.
Based on Type, the Nasal Spray Vaccine Market is segmented into Decongestion Nasal Spray, Steroid Nasal Spray, and Saltwater Solution/Saline Nasal Spray. Amongst Type, the Decongestion Nasal Spray segment of the market was valued at USD XX billion in 2020 and is likely to reach USD XX billion by 2027 growing at a CAGR of XX% from 2021-2027.
Based on Prescription, the Nasal Spray Vaccine Market is segmented into Over-The-Counter and Prescribed. Prescribed segment accounted for a market valuation of USD XX billion in 2020 and is expected to reach USD XX billion by the year 2027, at a CAGR of XX% over the analyzed period.
Based on Type of Therapeutics, the Nasal Spray Vaccine Market is segmented into Antihistamine, Nasal Steroids, Anticholinergic, Mast Cell Inhibitor. Amongst Therapeutic, the Antihistamine segment of the market was valued at USD XX billion in 2020 and is likely to reach USD XX billion by 2027 growing at a CAGR of XX% from 2021-2027.
For a better understanding of the market adoption of Nasal Spray Vaccine Industry, the market is analyzed based on its presence in the regions such as North America (US, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific), Rest of World. North America will dominate the Nasal Spray Vaccine market on account of increasing treatment and diagnosis of Nasal Spray Vaccine.
Some of the major players operating in the market include Akorn, Allergan, Apotex Inc, Bharat Biotech, Catalent Inc, Cipla Limited, GlaxoSmithKline, Johnson and Johnson, Novartis International AG, Pfizer Inc. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.
Nasal Spray Vaccine Market was valued at USD XX billion in 2020 and is projected to expand significantly with a CAGR of ~8% from 2021-2027F to USD XX billion in 2027. The Nasal Spray Vaccine Market is expected to witness a boost on account of its high adoption in the North America region.

Products


Companies

Akorn, Allergan, Apotex Inc, Bharat Biotech, Catalent Inc, Cipla Limited, GlaxoSmithKline, Johnson and Johnson, Novartis International AG, Pfizer Inc.

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Limitation

1.3. Stake Holders

1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Nasal Spray Vaccine Market

2.2. Research Methodology of the Nasal Spray Vaccine Market

2.3. Forecasting Method

2.4. Respondent Profile

2.5. Main Objective of the Nasal Spray Vaccine Market Study

3 MARKET SYNOPSIS (INDUSTRY AT A GLANCE)

4 EXECUTIVE SUMMARY

5 NASAL SPRAY VACCINE MARKET COVID-19 IMPACT

6 NASAL SPRAY VACCINE MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY TYPE

7.1. Decongestion Nasal Spray

7.2. Steroid Nasal Spray

7.3. Saltwater Solution/Saline Nasal Spray

8 MARKET INSIGHTS BY PRESCRIPTION

8.1. Over-The-Counter

8.2. Prescribed

9 MARKET INSIGHTS BY TYPE OF THERAPEUTICS

9.1. Antihistamine

9.2. Nasal Steroids

9.3. Anticholinergic

9.4. Mast Cell Inhibitor

10 MARKET INSIGHTS BY END-USER

10.1. Hospital

10.2. Ambulatory Surgery Centers

10.3. Home Care Settings

10.4. Clinics and others

11 MARKET INSIGHTS BY REGION

11.1. NORTH AMERICA NASAL SPRAY VACCINE

11.1.1. United States

11.1.2. Canada

11.1.3. Rest of North America

11.2. EUROPE NASAL SPRAY VACCINE

11.2.1. Germany

11.2.2. United Kingdom

11.2.3. France

11.2.4. Spain

11.2.5. Italy

11.2.6. Rest of Europe

11.3. ASIA-PACIFIC NASAL SPRAY VACCINE

11.3.1. China

11.3.2. Japan

11.3.3. India

11.3.4. Aurstralia

11.3.5. Rest of Asia-Pacific

11.4. REST OF THE WORLD NASAL SPRAY VACCINE

12 NASAL SPRAY VACCINE MARKET DYNAMICS

12.1. Drivers

12.2. Challenges

12.3. Impact Analysis

13 NASAL SPRAY VACCINE MARKET OPPORTUNITIES

14 NASAL SPRAY VACCINE MARKET TRENDS

15 LEGAL AND REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

16.1. Demand Side Analysis

16.2. Supply Side Analysis

16.2.1. Top Product Launches

16.2.2. Top Business Partnerships

16.2.3. Top Business Expansions, Investments and Divestitures

16.2.4. Top Merger and Acquisitions

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

18.1. Competitive Landscape

18.1.1. Company Shares, By Revenue

19 COMPANY PROFILED

19.1. Akorn

19.2. Allergan

19.3. Apotex Inc.

19.4. Bharat Biotech

19.5. Catalent Inc.

19.6. Cipla Limited

19.7. GlaxoSmithKline

19.8. Johnson and Johnson

19.9. Novartis International AG

19.10. Pfizer Inc.

20 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022